For Takeda, the deal brings it close to its goal of $10 billion in asset disposals, as Japan’s largest drugmaker attempts to shed some of the $31 billion in debt that the Shire acquisition added to its balance sheet
To read the entire story, you must be logged in.
Please log in now or register with us.
